[ad_1]
Today (Thursday), the Ministry of Health announced that 375 new cases of coronavirus have been recorded in the Kingdom, while 336 recoveries and 4 deaths have been recorded. According to “Health” statistics, the total number of cumulative cases since the first case in the Kingdom has reached 378,708 cases; Among them, 2,581 active cases are still receiving necessary health care, of which 503 are critical cases, while the total number of recovering cases has reached 369,613 cases, while the death toll has risen to 6,514 deaths. In this context, the Deputy Minister of Health, spokesperson for the ministry, Dr Muhammad Al-Abd Al-Aali, announced that those who had received the vaccine against the emerging corona virus could not come into contact with the person. infected with the virus, describing it as very dangerous.
He added: “It is true that if a person has been vaccinated with the vaccine, has acquired immunity, has reached the level of vaccination and has passed the time period for high immunity, he does not have to put himself on the line. quarantined in case of contact, but it is not. means that he is not bound by the rest of the precautionary measures that guarantee his own safety and that of others, because individual immunity is a step. But we must all achieve societal immunity. “
During his speech at the press conference to reveal the developments of the Corona virus and vaccines in the Kingdom, Dr Abdulali pointed out that rumors of low immunity, the possibility of infection and the onset of symptoms for a period than 3 weeks after receiving the first dose are wrong.
Regarding the preference of some for the Corona vaccine over other vaccines, and some deliberately not taking the AstraZeneca-Oxford vaccine on the pretext that the Pfizer vaccine is more effective, a spokesperson for the Department of Health said said: “The Pfizer and AstraZeneca approved vaccines in the Kingdom, and both have started studying them at advanced research centers and with a few partnerships. Among the leading companies in these fields, leading scientific teams and experts in these fields, and in partnership with prestigious universities such as the University of Oxford, the results and research which went through several stages were reliable in the scientific community and, most importantly, they have been approved and approved by the Food and Drug Authority of the Kingdom.
He added: “The studies that have been – and still are – on the two vaccines for use in companies, these studies include some indicating that the AstraZeneca vaccine is better in certain characteristics, and some of them indicating that the vaccine Pfizer is better in other characteristics, but the differences between the two vaccines are limited in these characteristics. Both achieve very high efficacy and safety rates. “
[ad_2]
Source link
